ESC-EAPCI工作组关于生物可吸收支架评估与使用的报告:执行摘要
欧洲心脏病学会与欧洲经皮心血管介入协会工作组应欧盟委员会要求,针对生物可吸收支架(BRS)撰写额外报告。目前有五种BRS获CE认证,仅Absorb有随机临床试验数据,显示2-3年预后劣于传统药物洗脱支架(DES),因此当前临床实践不应优先选用BRS。工作组建议新BRS在临床研究前需按标准化标准进行系统非临床测试,临床评估计划应包括针对DES的中型随机试验,使用临床疗效替代终点;成功获批的制造商须制定大规模随机试验及长期随访计划。
要点
- 当前BRS不应优先于传统DES用于临床实践。
- 新BRS需按标准化标准进行系统非临床测试后再开展临床研究。
- 临床评估需包括针对DES的中型随机试验,以临床疗效替代终点为动力。
核心结论
- 目前BRS在临床实践中不应优先于传统DES。
- 新BRS设备需经系统非临床测试和特定临床评估计划后方可考虑应用。
研究设计与样本
- ESC与EAPCI工作组应欧盟委员会要求撰写的报告,针对BRS类器械的评估与使用提出建议。
主要发现
- 五种BRS获CE认证用于欧洲,仅Absorb生物可吸收血管支架有已发表的随机临床试验数据。
- Absorb在2-3年时的结局劣于传统DES。
关键数值与推荐
- 新BRS设备在临床研究前应按标准化标准进行系统非临床测试。
- 临床评估计划应包括针对DES的中型随机试验,以临床疗效替代终点为动力。
- 成功设备的制造商获CE认证后须有批准的大规模随机临床试验计划及长期随访。
临床怎么用
- 临床实践中不优先选用BRS,仍以传统DES为标准。
- 关注新BRS的非临床测试和随机试验证据后方可考虑使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A previous Task Force of the European Society of Cardiology (ESC) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) provided a report on recommendations for the non-clinical and clinical evaluation of coronary stents. Following dialogue with the European Commission, the Task Force was asked to prepare an additional report on the class of devices known as bioresorbable scaffolds (BRS). Five BRS have CE-mark approval for use in Europe. Only one device-the Absorb bioresorbable vascular scaffold-has published randomized clinical trial data and this data show inferior outcomes to conventional drug-eluting stents (DES) at 2-3 years. For this reason, at present BRS should not be preferred to conventional DES in clinical practice. The Task Force recommends that new BRS devices should undergo systematic non-clinical testing according to standardized criteria prior to evaluation in clinical studies. A clinical evaluation plan should include data from a medium sized, randomized trial against DES powered for a surrogate end point of clinical efficacy. Manufacturers of successful devices receive CE-mark approval for use and must have an approved plan for a large-scale randomized clinical trial with planned long-term follow-up.
引用
- Byrne RA, Stefanini GG, Capodanno D, et al. Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. Eur Heart J. 2018. PMID: 29020259. doi:10.1093/eurheartj/ehx488
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。